Conferences of the
Department of Internal Medicine - Cardiology
on Cardiovascular Diseases Associated with Inflammation
 
 

Extramural Education and Training Program
of the European Society of Cardiology:

RECENT ADVANCES IN PERICARDIAL DISEASES
AND CARDIAC INFLAMMATION

November 7-9th, 2002, Marburg
 


The final program (October 30, 2002)
can be downloaded here


 



 
  • PHYSIOLOGY, PATHOPHYSIOLOGY, MACRO- AND HISTOPATHOLOGY OF THE PERICARDIUM AND CARDIAC INFLAMMATION
  • DIAGNOSTIC TOOLS
  • PERICARDIOCENTESIS AND PERICARDIOSCOPY - LIVE
  • RECENT ADVANCES IN DIAGNOSTICS
  • "HANDS-ON" SESSION
  • MANGEMENT OF MYOCARDIAL AND PERICARDIAL DISEASES: MEDICAL,  INTERVENTIONAL, AND SURGICAL TREATMENT
  • MANAGEMENT OF PERICARDIAL DISEASES INTRAPERICARDIAL TREATMENT
 Course directors: 
B. MAISCH F.E.S.C. (Marburg, DE)
P.M. SEFEROVIC, F.E.S.C. (Belgrade, YU)

Faculty:
Y. ADLER (Tel Hashomer, IS), N. ANGOMACHALELIS (Thessaloniki, GR), E. ARBUSTINI (Pavia, IT), U. BAANDRUP (Aarhus, DK), C. CIPOLLA (Milan, IT), R. ERBEL, F.E.S.C. (Essen, DE), R. FUNCK (Marburg, DE), K.J. KLOSE (Marburg, DE), S. LAMPARTER (Marburg, DE), R. MOLL (Marburg, DE), R. MOOSDORF (Marburg, DE), A. NEUBAUER (Marburg, DE), S. PANKUWEIT (Marburg, DE), R. RIENMÜLLER (Graz, AU), A.D. RISTIC, F.E.S.C. (Belgrade, YU), H. RUPP (Marburg, DE), R. SHABETAI (San Diego, USA), H-P. SCHULTHEISS, F.E.S.C. (Berlin, DE), 

Organisation and address of the course location:
Department of Internal Medicine & Cardiology, Philipps-University Marburg, Tel: +49-6421-2866462, Fax: +49-6421-2868954;
email: maisch@mailer.uni-marburg.de or BerMaisch@AOL.COM
Local Organising Committee: S. PANKUWEIT, V. RUPPERT, S. LAMPARTER and H. RUPP

A detailed program and registration form can be donwnloaded as PDF file:

ETP Course: Pericardial diseases (580 kB)
requires Acrobat Reader (version > 4.0)
 
 
 
 
 
 
 

From Genes to Therapy in Coronary Heart Disease and Cardiomyopathy
October 8 - 9, 1999
Dept.  of Internal Medicine and Cardiology, Heart Center,  Philipps University of Marburg

The proceedings of the conference have been published in two special issues of Herz-Cardiovascular Diseases (2000) vol 25 "From Genes to Therapy in Coronary Heart Disease and Cardiomyopathy" and are available online: Part 1:Coronary Artery Disease Part 2:Cardiomyopathy
Part 3: The Pericardium and its Diseases
 

Selected contributions with abstracts::


  • M. Maass, Lübeck, Germany

    • Chlamydia pneumoniae and atherosclerosis
  • M. Herzum, Marburg, Germany

    • Restenosis and infectious pathogenesis - CMV and Cp as pathogenic factors
  • W. Haberbosch, Giessen, Germany

    • Chlamydia pneumoniae infection is not an independent risk factor for arterial disease
  • G. Wick, Innsbruck, Austria

    • Heat shock proteins in the development of atherosclerosis
     
  • S. Bhakdi, Mainz, Germany
  • Immunopathogenesis of atherosclerosis - the Mainz concept

    • Isolation of Chlamydia-reactive T cells from atheromatous plaques
  • M. C. Deng, Münster, Germany

    • Transplantation vasculopathy - a model for CAD?
  • L. Biasucci, Rome, Italy

    • Inflammation and unstable coronary syndromes
  • B. Simon, Marburg, Germany

    • Role of TGF-beta in coronary atherosclerosis and vascular remodelling following coronary interventions
     
  • K. Klingel, Tübingen, Germany

    • Enteroviral persistence and myocyte injury
  • K.U. Knowlton, San Diego, USA

    • Coxsackieviral protease 2A directly cleaves dystrophin in the hinge 3 region: cytoskeletal disruption in an aquired cardiomyopathy
  • P. L. Schwimmbeck, Berlin, Germany

    • Enteroviral and immune mediated myocarditis in SCID-mice
  • U. Lotze, Jena, Germany

    •  Apoptosis in enterovirus-associated dilated cardiomyopathy
     
  • S. Tracy, Omaha, USA

    • Vaccines against enteroviral infection
  • A. Richter, G. Hufnagel, S. Pankuweit, A. Wilke, B. Maisch, Marburg, Germany

    • Familial DCM with inflammation - a new entity?
  • U. Müller-Werdan, Halle, Germany

    • Evidence for a link between catecholamines and interleukin-6 release from cardiomyocytes
  • W. Grimm, Marburg, Germany

    • Arrhythmia risk stratification in cardiomyopathy
     
  • E. Arbustini, Pavia, Italy

    • Genetics of idiopathic dilated cardiomyopathies
  • N. Bowles, Houston, USA

    • Genetics of cytoskeletal proteins in cardiomyopathies
  • V. Ruppert, B. Maisch, Marburg, Germany

    • Mitochondrial deletions in cardiomyopathy
  • N. Angomachalelis, Thessaloniki, Greece

    • Diagnostic approaches in non-inflammatory cardiomyopathy
     
  • B. Maisch, Marburg, Germany

    • New criteria for chronic inflammatory cardiomyopathy
  • G. Thiene, Padua, Italy

    • Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy
  • H. P. Schultheiss, Berlin, Germany

    • The role of the adenine nucleotide translocator in dilated cardiomyopathy and myocarditis
  • A. Matsumori, Kyoto, Japan

    • Hepatitis C virus infection and cardiomyopathy
  • G. Hufnagel, B. Maisch, Marburg, Germany

    • The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) - First epidemiological results
     
     
  • U. Baandrup, Aarhus, Denmark

    • Histology of inflammation in myocarditis and pericarditis
  • P. Seferovic, Belgrade, Yugoslavia

    • Role of pericardioscopy in pericardial disease
  • S. Pankuweit, B. Maisch, Marburg, Germany

    • Cytokine activation in pericardial fluids in different forms of pericarditis
  • A. Ristic, B. Maisch, Marburg, Germany

    • Intrapericardial treatment of autoimmune and neoplastic pericardial effusion: long-term experience with triamcinolone and cis-platin
  • W. März, Freiburg, Germany

    • HMG-CoA reductase inhibition -anti-inflammatory effects beyond lowering lipids
     
  • T. Izumi, Niagata, Japan

    •  Experimental autoimmune myocarditis and its pathomechanism
  • G. Wallukat, Berlin, Germany

    • Autoantibodies against beta- and muscarinic receptors in cardiomyopathy
  • M.L.X. Fu, Göteborg, Sweden

    • G-protein coupled receptor-related autoimmunity in cardiomyopathy
  • L.T. Cooper, Rochester, USA

    • Giant cell myocarditis - diagnosis and treatment
     
     
  • J.R. Schaefer, Marburg, Germany

    • Cholesterol and lipid lowering drugs in coronary artery disease
  • G. Pierce, Winnipeg, Canada

    • Cellular effects of oxidized LDL in the vasculature
  • F. Waagstein, Göteborg, Sweden

    • Beta blockers in cardiomyopathy
  • E. Öhm, V. Mitrovic, Bad Nauheim, Germany

    •  Potassium channel blockers vs. beta-adrenoceptor blockers and calcium antagonists in CAD
  • C.G. Brilla, Marburg, Germany

    • Antifibrotic effects of aldosterone antagonists
     
     
  • J. Müller, G. Wallukat, R. Hetzer, Berlin, Germany

    • Immunoadsorption in dilated cardiomyopathy
  • G. Neufeld, Haifa, Israel

    • VEGF isoforms and their properties - which may be the clinical relevance?
  • H. Rupp, B. Maisch, Marburg, Germany

    • Intrapericardial gene transfer in rats
  • K.A. Kadipasaoglu, Houston, USA

    • Transmyocardial laser revascularization: effect of laser parameters on tissue ablation and cardiac perfusion
  • R. Moosdorf, Marburg, Germany

    • Transmyocardial laser revascularization and gene transfer